In focus · trending topic

PRODUCT. INTERNATIONAL

7 stories · following the connections

Apricus Biosciences Announces Sale of Ex-U.S. Vitaros Assets and Rights to Ferring Pharmaceuticals

By Nasdaq OMXMar 8, 2017, 9:01 PM UTC

Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico

By Nasdaq OMXJan 18, 2017, 12:00 PM UTC

Apricus Biosciences Announces the Launch of Vitaros® for the Treatment of Erectile Dysfunction in Lebanon by Elis Pharmaceuticals

By Nasdaq OMXDec 27, 2016, 12:00 PM UTC

Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Greece

By Nasdaq OMXOct 26, 2016, 11:00 AM UTC

Apricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by Recordati

By Nasdaq OMXSep 21, 2016, 11:00 AM UTC

Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Argentina

By Nasdaq OMXSep 8, 2016, 11:00 AM UTC

Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Portugal, Ireland and Poland by Recordati

By Nasdaq OMXSep 6, 2016, 11:00 AM UTC